1Bahlis NJ,MeCafferty-Gred J,Jordan-McMurry I,et a1.Feasibility and eorrelate8 of arsenic trioxide combined with ascerbic acid-Mediated depletion of intmceHular ghtathione for the treatment of relapsed/refractory multiple myeloma.Clin Cancer Res,2002,8:3658-3668.
2Deaglio S,Canella D,Baj G,et al.Evidence of an immunolagic mechanism behind the therapeutical effexts of arsenic trioxide(As2O3)on myeloma cells.Leuk Res,2001,25:227-235.
